The genomic and transcriptional landscape of primary central nervous system lymphoma
Josefine Radke(Universitätsmedizin Greifswald), Chris Lawerenz(German Cancer Research Center), Peter Vajkoczy(Humboldt-Universität zu Berlin), Debora Pehl(Humboldt-Universität zu Berlin), Randi Koll(Humboldt-Universität zu Berlin), Anja Osterloh(Humboldt-Universität zu Berlin), Xavier Pastor Hostench(National Center for Tumor Diseases), Andreas Unterberg(Heidelberg University), Shashwat Sahay(Universitätsmedizin Greifswald), Michael Hummel(Charité - Universitätsmedizin Berlin), Susanne Wagner(Christian-Albrechts-Universität zu Kiel), Katharina Faust(Charité - Universitätsmedizin Berlin), Christel Herold‐Mende, Elisa Schumann(Humboldt-Universität zu Berlin), Gnana Prakash Balasubramanian(German Cancer Research Center), Stephan Wolf(German Cancer Research Center), Clemens A. Schmitt(Kepler Universitätsklinikum), Dido Lenze(Franklin University), Roland Eils(Heidelberg University), Andreas Jödicke(Vivantes Klinikum), Zuguang Gu(German Cancer Research Center), Lina Sieverling(German Cancer Research Center), Martin Misch(Humboldt-Universität zu Berlin), Naveed Ishaque(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Nagarajan Paramasivam(National Center for Tumor Diseases), Dilafruz Juraeva(National Center for Tumor Diseases), Benedikt Brors(German Cancer Research Center), Simone Borgoni(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Julia Onken(German Society of Surgery), Matthias Schlesner(Radboud University Nijmegen), Fabienne Pritsch(Humboldt-Universität zu Berlin), Dag Moskopp(Klinikum im Friedrichshain), Gesine Richter(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Reiner Siebert(Universität Ulm), Sebastian Uhrig(German Cancer Research Center), Agnieszka Korfel(Eli Lilly (Germany)), Ralf Küppers(University of Duisburg-Essen), Ioannis Anagnostopoulos(Humboldt-Universität zu Berlin), Yawen Wang(University of Hong Kong), Umut H. Toprak(German Cancer Research Center), Marc A. Weniger(Deutschen Konsortium für Translationale Krebsforschung), Otmar D. Wiestler(University of Bonn), Daniel Hübschmann(German Cancer Research Center), Lorenz Trümper(University of Göttingen), Helena Radbruch(Charité - Universitätsmedizin Berlin)
Cited by 140
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
<scp>SARS</scp> ‐CoV‐2 receptor <scp>ACE</scp> 2 and <scp>TMPRSS</scp> 2 are primarily expressed in bronchial transient secretory cells
|The EMBO Journal|2020|1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k